# Moonlight Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/moonlight-therapeutics

- Industry: Biotechnology
- Headquarters: Atlanta, US
- Website: www.moonlighttx.com/
- Latest round: Seed (Jun 30, 2025)
- Investors on record: 1

## About

Founded in 2017 and based in Georgia, US, Moonlight Therapeutics Inc. operates as a biotechnology company that develops treatments for food allergies. The company was co-founded by CEO Dr. Samir Patel, COO Dr. Vladimir Zarnitsyn, and Dr. Harvinder Gill. In October 2025, Moonlight Therapeutics Inc. received an undisclosed amount of grant funding from new investor CDMRP.

The company is focused on developing treatments for people suffering from food allergies. Moonlight Therapeutics offers its platform, TASIS — Targeted Allergen-Specific Immunotherapy which involves the application of a dermal stamp that uses microneedles to desensitize patients from food allergies.

The company will use the October 2025 funding to start clinical trials for MOON101 in peanut-allergic individuals and to expand its immunotherapy platform to treat other food allergies.

## Funding rounds

- Seed, Jun 30, 2025 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed